Cargando…
Reduction-responsive nucleic acid nanocarrier-mediated miR-22 inhibition of PI3K/AKT pathway for the treatment of patient-derived tumor xenograft osteosarcoma
miRNAs are important regulators of gene expression and play key roles in the development of cancer, including osteosarcoma. During the development of osteosarcoma, the expression of miR-22 is significantly downregulated, making miR-22 as a promising therapeutic target against osteosarcoma. To design...
Autores principales: | Chen, Dafu, Lei, Chengyue, Liu, Weifeng, Shao, Meiyu, Sun, Meizhou, Guo, Jianxun, Cao, Jingjing, Nie, Jing-Jun, Luo, Peng, Luo, Yuwen, Yu, Bingran, Wang, Renxian, Duan, Shun, Xu, Fu-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382964/ https://www.ncbi.nlm.nih.gov/pubmed/37519923 http://dx.doi.org/10.1016/j.bioactmat.2023.05.012 |
Ejemplares similares
-
Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma
por: Chen, Dafu, et al.
Publicado: (2023) -
Therapeutic Potential of Circular RNAs in Osteosarcoma
por: Wan, Ben, et al.
Publicado: (2020) -
Analysis of Immune Gene Expression Subtypes Reveals Osteosarcoma Immune Heterogeneity
por: Wan, Ben, et al.
Publicado: (2021) -
Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma
por: Wang, Renxian, et al.
Publicado: (2023) -
Building Osteogenic Microenvironments With Strontium-Substituted Calcium Phosphate Ceramics
por: Wan, Ben, et al.
Publicado: (2020)